JP2018138049A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018138049A5 JP2018138049A5 JP2018088729A JP2018088729A JP2018138049A5 JP 2018138049 A5 JP2018138049 A5 JP 2018138049A5 JP 2018088729 A JP2018088729 A JP 2018088729A JP 2018088729 A JP2018088729 A JP 2018088729A JP 2018138049 A5 JP2018138049 A5 JP 2018138049A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- amino acid
- acid sequence
- seq
- nos
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011098270 | 2011-04-26 | ||
| JP2011098270 | 2011-04-26 | ||
| JP2011219454 | 2011-10-03 | ||
| JP2011219454 | 2011-10-03 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016214996A Division JP6336549B2 (ja) | 2011-04-26 | 2016-11-02 | 組織再生を誘導するためのペプチドとその利用 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019175276A Division JP2020058344A (ja) | 2011-04-26 | 2019-09-26 | 組織再生を誘導するためのペプチドとその利用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018138049A JP2018138049A (ja) | 2018-09-06 |
| JP2018138049A5 true JP2018138049A5 (enExample) | 2018-12-13 |
| JP6603964B2 JP6603964B2 (ja) | 2019-11-13 |
Family
ID=47071995
Family Applications (6)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013511983A Active JP6069191B2 (ja) | 2011-04-26 | 2012-04-03 | 組織再生を誘導するためのペプチドとその利用 |
| JP2016214996A Active JP6336549B2 (ja) | 2011-04-26 | 2016-11-02 | 組織再生を誘導するためのペプチドとその利用 |
| JP2018088729A Active JP6603964B2 (ja) | 2011-04-26 | 2018-05-02 | 組織再生を誘導するためのペプチドとその利用 |
| JP2019175276A Pending JP2020058344A (ja) | 2011-04-26 | 2019-09-26 | 組織再生を誘導するためのペプチドとその利用 |
| JP2021129955A Pending JP2021191271A (ja) | 2011-04-26 | 2021-08-06 | 組織再生を誘導するためのペプチドとその利用 |
| JP2023084251A Pending JP2023106525A (ja) | 2011-04-26 | 2023-05-23 | 組織再生を誘導するためのペプチドとその利用 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013511983A Active JP6069191B2 (ja) | 2011-04-26 | 2012-04-03 | 組織再生を誘導するためのペプチドとその利用 |
| JP2016214996A Active JP6336549B2 (ja) | 2011-04-26 | 2016-11-02 | 組織再生を誘導するためのペプチドとその利用 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019175276A Pending JP2020058344A (ja) | 2011-04-26 | 2019-09-26 | 組織再生を誘導するためのペプチドとその利用 |
| JP2021129955A Pending JP2021191271A (ja) | 2011-04-26 | 2021-08-06 | 組織再生を誘導するためのペプチドとその利用 |
| JP2023084251A Pending JP2023106525A (ja) | 2011-04-26 | 2023-05-23 | 組織再生を誘導するためのペプチドとその利用 |
Country Status (12)
| Country | Link |
|---|---|
| US (4) | US10364276B2 (enExample) |
| EP (2) | EP2703487B1 (enExample) |
| JP (6) | JP6069191B2 (enExample) |
| KR (2) | KR102113809B1 (enExample) |
| CN (3) | CN107188948B (enExample) |
| AU (4) | AU2012248676B2 (enExample) |
| CA (1) | CA2834255C (enExample) |
| DK (2) | DK2703487T3 (enExample) |
| ES (2) | ES2684718T3 (enExample) |
| PL (2) | PL3358011T3 (enExample) |
| PT (2) | PT3358011T (enExample) |
| WO (1) | WO2012147470A1 (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5676253B2 (ja) | 2008-04-30 | 2015-02-25 | 株式会社ジェノミックス | 生体内機能的細胞の高効率採取法 |
| JP5865703B2 (ja) | 2009-10-28 | 2016-02-17 | 株式会社ジェノミックス | 骨髄間葉系および／または多能性幹細胞の血中動員による組織再生促進剤 |
| ES2660420T3 (es) | 2012-10-25 | 2018-03-22 | Genomix Co., Ltd. | Método novedoso para tratar infarto cardiaco utilizando fragmento de HMGB1 |
| US9688733B2 (en) | 2012-10-25 | 2017-06-27 | Genomix Co., Ltd. | Method for treating spinal cord injury using HMGB1 fragment |
| EP3888640B1 (en) | 2013-06-05 | 2025-09-17 | Reverse Bioengineering, Inc. | Compositions and methods for induced tissue regeneration in mammalian species |
| EP3291843B1 (en) | 2015-05-07 | 2023-03-22 | University of South Florida | Modified ube3a gene for a gene therapy approach for angelman syndrome |
| CN108779435B (zh) | 2015-12-07 | 2022-05-03 | 再生疗法有限公司 | 用于重新衍生不同的多能干细胞衍生的褐色脂肪细胞的方法 |
| CN106995796A (zh) * | 2016-01-26 | 2017-08-01 | 李建业 | 基于细胞因子的细胞处理方法、试剂盒及冻干粉 |
| JP2019523633A (ja) * | 2016-04-29 | 2019-08-29 | アライム ファーマシューティカルズ，インコーポレーテッド | 組織の損傷に関連した疾患及び障害を予防及び治療する組織保護ペプチド |
| AU2017332367B2 (en) * | 2016-09-21 | 2021-12-23 | Stephen H. Thorne | High mobility group box i mutant |
| EP3556378B1 (en) | 2017-01-27 | 2025-03-12 | StemRIM Inc. | Therapeutic agent for cardiomyopathy, old myocardial infarction and chronic heart failure |
| US20200038486A1 (en) * | 2017-04-07 | 2020-02-06 | StemRIM Inc. | Therapeutic medicine for fibrous disease |
| CA3059544A1 (en) * | 2017-04-25 | 2018-11-01 | Shionogi & Co., Ltd. | Peptide for inducing regeneration of tissue, and use thereof |
| CN111542335A (zh) * | 2017-12-01 | 2020-08-14 | 斯特姆里姆有限公司 | 炎症性肠病的治疗药 |
| CN111868231B (zh) | 2017-12-01 | 2024-05-31 | 斯特姆里姆有限公司 | 外胚层间充质干细胞及其产生方法 |
| US20210024594A1 (en) * | 2018-02-08 | 2021-01-28 | StemRIM Inc. | Therapeutic Agent for Psoriasis |
| WO2020071520A1 (ja) | 2018-10-05 | 2020-04-09 | 株式会社ステムリム | 間葉系幹細胞の動員活性を有するペプチド |
| US12304933B2 (en) | 2018-10-05 | 2025-05-20 | StemRIM Inc. | Disease treatment drug based on mesenchymal-stem-cell mobilization |
| CA3117107A1 (en) | 2018-10-25 | 2020-04-30 | Osaka University | Therapeutic agent for cartilage disorder |
| US20220175940A1 (en) * | 2019-03-26 | 2022-06-09 | Niigata University | Peptide and use thereof |
| CN109957015A (zh) * | 2019-04-01 | 2019-07-02 | 中国人民解放军海军军医大学国家肝癌科学中心 | 一种hmgb1封闭性抗体的制备方法及其应用 |
| AU2020385059A1 (en) * | 2019-11-12 | 2022-06-02 | Oxford University Innovation Limited | Polypeptides related to HMGB1 useful for promoting tissue regeneration, compositions comprising same, and uses thereof |
| IL296982B2 (en) * | 2020-04-03 | 2026-04-01 | Stemrim Inc | Peptide with mesenchymal stem cell migration activity |
| EP4147711A4 (en) * | 2020-04-20 | 2024-04-24 | Shionogi & Co., Ltd | FORMULATION WITH A HMGB1 PARTIAL PEPTIDE |
| US20250019405A1 (en) * | 2020-04-22 | 2025-01-16 | Chulalongkorn University | A Composition and A Method of Rejuvenating DNA and Preventing DNA Damage |
| US20240018588A1 (en) * | 2020-12-07 | 2024-01-18 | Samsung Life Public Welfare Foundation | Method for selecting mesenchymal stem cells having improved self-maintenance ability, and mesenchymal stem cells selected thereby |
| WO2022243932A1 (en) * | 2021-05-19 | 2022-11-24 | Oxford University Innovation Limited | Polypeptides related to hmgb1 useful for promoting tissue regeneration, compositions comprising same, and uses thereof |
| AU2021466375A1 (en) | 2021-09-30 | 2024-04-11 | Niigata University | Drug for treating fatty liver and non-alcoholic steatohepatitis |
| CN116983471B (zh) * | 2023-06-07 | 2024-03-08 | 华中科技大学同济医学院附属协和医院 | 一种基于α-螺旋双亲性多肽的超分子共组装凝胶的制备方法及应用 |
Family Cites Families (66)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5238680B2 (enExample) | 1972-12-27 | 1977-09-30 | ||
| US4732155A (en) | 1985-08-27 | 1988-03-22 | The Children's Medical Center Corporation | Implantable chemoattractant system |
| US5658894A (en) | 1989-04-23 | 1997-08-19 | The Trustees Of The University Of Pennsylvania | Compositions for inhibiting restenosis |
| US5661127A (en) | 1995-05-01 | 1997-08-26 | The Regents Of The University Of California | Peptide compositions with growth factor-like activity |
| JP3018313B2 (ja) | 1996-02-23 | 2000-03-13 | 雪印乳業株式会社 | 骨形成促進及び骨吸収防止剤 |
| US20040031072A1 (en) * | 1999-05-06 | 2004-02-12 | La Rosa Thomas J. | Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement |
| ATE440602T1 (de) | 1999-07-28 | 2009-09-15 | Univ Leland Stanford Junior | Nicotinrezeptoragonisten in stammzellen und vorlaüferzellinduktion |
| JP2003517858A (ja) | 1999-11-05 | 2003-06-03 | ジェリジーン メディカル コーポレーション | 老齢関連の軟組織の欠陥の増強と修復 |
| EP1114862A3 (de) | 1999-11-17 | 2003-08-06 | Switch Biotech Aktiengesellschaft | Verwendung von Polypeptiden oder diese kodierende Nukleinsäuren zur Diagnose oder Behandlung von Hauterkrankungen sowie ihre Verwendung zur Identifizierung von pharmakologisch aktiven Substanzen |
| KR20030032922A (ko) | 2000-02-24 | 2003-04-26 | 싸이트 테라피스 인코포레이티드 | 세포의 동시 자극 및 농축 |
| JP3421741B2 (ja) | 2000-05-18 | 2003-06-30 | 筑波大学長 | 人工骨髄、血球細胞の増殖方法 |
| US7754217B2 (en) | 2001-03-16 | 2010-07-13 | Bio3 Research Srl | HMGB1 protein inhibitors and/or antagonists for the treatment of vascular diseases |
| DE10121254A1 (de) | 2001-04-30 | 2002-11-07 | Switch Biotech Ag | MRP8/MRP14 Heterodimers oder seiner Einzelkomponenten alleine oder in Kombination zur Behandlung und/oder Prävention von Hauterkrankungen, Wunden und/oder Wundheilungsstörungen, die durch eine verringerte Menge an MRP8/MRP14 Heterodimeren gekennzeichnet sind |
| EP1390058A2 (en) | 2001-04-30 | 2004-02-25 | Switch Biotech Aktiengesellschaft | Mrp8/mrp14 heterodimer, or its individual components in combination, for treating and/or preventing skin diseases, wounds and/or wound-healing disturbances |
| US7304034B2 (en) | 2001-05-15 | 2007-12-04 | The Feinstein Institute For Medical Research | Use of HMGB fragments as anti-inflammatory agents |
| CN100447154C (zh) | 2001-05-15 | 2008-12-31 | 费因斯坦医学研究学院 | 利用hmg片段作为抗炎症试剂 |
| US7220723B2 (en) | 2001-05-15 | 2007-05-22 | The Feinstein Institute For Medical Research | Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents |
| ITMI20011986A1 (it) | 2001-09-25 | 2003-03-25 | San Raffaele Centro Fond | Metodo e composizione per l'attivazione di cellule presentanti l'antigene |
| CA2467557A1 (en) | 2001-11-19 | 2003-05-30 | Kyowa Hakko Kogyo Co., Ltd. | Agent which mobilizes multipotential stem cells from tissues to peripheral blood |
| KR100930139B1 (ko) | 2001-12-07 | 2009-12-07 | 사이토리 테라퓨틱스, 인크. | 처리된 리포애스퍼레이트 세포로 환자를 치료하기 위한시스템 및 방법 |
| FR2833609B1 (fr) | 2001-12-19 | 2004-12-03 | Natural Implant | Dispositif de prelevement cellulaire ou tissulaire en phase active et utilisations |
| AU2003228099A1 (en) * | 2002-07-03 | 2004-01-23 | Centro Cardiologico Monzino S.P.A.-Irccs | Use of hmgb1 in the treatment of tissue damage and/or to promote tissue repair |
| US7553488B2 (en) | 2002-07-05 | 2009-06-30 | UNIVERSITé LAVAL | Antibodies against S100A8 and S100A9 proteins for modulating inflammatory reactions |
| GB0226251D0 (en) | 2002-11-11 | 2002-12-18 | San Raffaele Centro Fond | Acetylated protein |
| JP2006510619A (ja) | 2002-11-20 | 2006-03-30 | クリティカル セラピューティクス，インコーポレイテッド | 抗炎症剤としてのｈｍｇｂ断片の使用 |
| US20040156851A1 (en) | 2002-11-20 | 2004-08-12 | Critical Therapeutics, Inc. | HMGB1 combination therapies |
| WO2004061456A2 (de) | 2003-01-03 | 2004-07-22 | Alcedo Biotech Gmbh | Verwendungen von hmgb, hmgn, hmga proteinen |
| WO2004075855A2 (en) | 2003-02-26 | 2004-09-10 | Biomed Solutions, Llc | Process for in vivo treatment of specific biological targets in bodily fluid |
| CN1193092C (zh) | 2003-03-28 | 2005-03-16 | 浙江大学 | 骨髓间充质干细胞分离和体外扩增培养方法 |
| EP1608397B1 (en) | 2003-03-28 | 2008-10-15 | Universite Laval | S100 protein as neutrophil activator for alleviating neutropenia in cancer treatment |
| US20090069227A9 (en) | 2003-04-29 | 2009-03-12 | Capogrossi Maurizio C | Use of HMGB1 to promote stem cell migration and/or proliferation |
| US20050014255A1 (en) | 2003-05-29 | 2005-01-20 | Board Of Regents, The University Of Texas System | Stem cells for clinical and commercial uses |
| WO2005025604A2 (en) | 2003-09-10 | 2005-03-24 | The General Hospital Corporation | Use of hmgb and hmgb fragments to decrease specific immune response |
| AU2004272607B2 (en) | 2003-09-11 | 2008-11-06 | Cornerstone Therapeutics Inc. | Monoclonal antibodies against HMGB1 |
| ITRM20040058A1 (it) | 2004-02-03 | 2004-05-03 | Marco E Bianchi | Inibitori ed antagonisti di hmgb1 in grado di regolare la proliferazione delle cellule muscolari lisce ed endoteliali. |
| JP2008507505A (ja) | 2004-07-20 | 2008-03-13 | プロヴィンシア・イタリアーナ・デッラ・コングレガチォーネ・フィリ・デッリマコラータ・コンセチォーネ−イスティトゥト・デルモパティコ・デッリマコラータ−アイ・アール・シー・シー・エス | 創傷治癒のためのｈｍｇｂ１の使用 |
| MX2007001155A (es) | 2004-07-29 | 2007-08-14 | Creabilis Therapeutics Spa | Uso de inhibidores de k-252a y de quinasa para la prevencion o el tratamiento de patologias asociadas con hmgb1. |
| JP5622351B2 (ja) | 2004-09-03 | 2014-11-12 | クレアビリス・セラピューティクス・エスピーエー | プロテアーゼ抵抗性ヒトおよび非ヒトＨＭＧＢ１Ｂｏｘ−Ａ変異体、ならびにそれらの治療／診断への使用 |
| WO2007001422A2 (en) * | 2004-10-22 | 2007-01-04 | Medimmune, Inc. | High affinity antibodies against hmgb1 and methods of use thereof |
| KR100593397B1 (ko) | 2004-10-27 | 2006-06-28 | 한국원자력연구소 | 중배엽 줄기세포 및/또는 ｐ 물질을 함유하는 상처 치유또는 상처 치유 촉진제, 또는 세포 치료제 |
| WO2006047820A1 (en) | 2004-11-01 | 2006-05-11 | Newsouth Innovations Pty Limited | Use of calgranulin a and b in the promotion and inhibition of mineralized tissue formation |
| ITRM20050032A1 (it) | 2005-01-21 | 2006-07-22 | Marco E Bianchi | Inibitori ed antagonisti di hmgb1 in grado di inibire la patogenesi e la progressione della malattia aterosclerotica. |
| JP5103626B2 (ja) | 2005-01-27 | 2012-12-19 | 財団法人ヒューマンサイエンス振興財団 | 間葉系幹細胞を含む細胞シート |
| ES2345837T3 (es) | 2005-03-23 | 2010-10-04 | Biosafe S.A. | Sistema integrado para la recogida, el procesamiento y el trasplante de subgrupos de celulas, incluyendo celulas madre adultas, para medicina regenerativa. |
| KR100775958B1 (ko) * | 2005-03-30 | 2007-11-13 | 김정문 | 조직재생 기능을 가지는 비활성 폴리펩티드 및 그 제조방법 |
| WO2006114805A2 (en) | 2005-04-28 | 2006-11-02 | Fondazione Centro San Raffaele Del Monte Tabor | Use of hmgb2 and hmgb3 proteins for medical applications |
| US20100280493A1 (en) | 2005-06-23 | 2010-11-04 | Asha Nayak | Methods and Systems for Treating Injured Cardiac Tissue |
| WO2007015546A1 (ja) | 2005-08-04 | 2007-02-08 | Genomix Co., Ltd | 間葉系幹細胞誘導剤及び組織再生促進剤並びに間葉系幹細胞の調製方法 |
| WO2007031100A1 (en) | 2005-09-14 | 2007-03-22 | Ostini, Marco | Active immunotherapy of life-threatening systemic inflammation |
| US20090155853A1 (en) * | 2005-11-18 | 2009-06-18 | Gary Nabel | Non-viral gene delivery complex |
| US7829097B2 (en) * | 2006-02-06 | 2010-11-09 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Use of HMGB1 for protection against ischemia reperfusion injury |
| JP4982739B2 (ja) | 2006-06-01 | 2012-07-25 | 国立大学法人 東京医科歯科大学 | ポリグルタミン病の予防・治療剤 |
| JP5244785B2 (ja) | 2006-08-11 | 2013-07-24 | 小野薬品工業株式会社 | ストローマ由来因子−１（ｓｄｆ−１）に対するモノクローナル抗体 |
| CA2663300C (en) | 2006-09-15 | 2014-10-07 | Creabilis Therapeutics S.P.A. | Polymer conjugates of box-a of hmgb1 and box-a variants of hmgb1 |
| BRPI0718491A2 (pt) * | 2006-09-15 | 2013-12-03 | Creabilis Therapeutics Spa | Conjugados poliméricos do box-a da hmgb1 e variantes do box-a da hmbg1 |
| ES2629086T3 (es) | 2006-10-30 | 2017-08-07 | Genomix Co., Ltd. | Sustancia farmacéutica para promover la regeneración funcional de tejido dañado |
| CA2629652A1 (en) | 2007-04-24 | 2008-10-24 | Yaojiong Wu | Compositions for preventing or treating skin defects and methods of use thereof |
| US8114668B2 (en) | 2007-05-14 | 2012-02-14 | Cardiac Pacemakers, Inc. | Composition for cold storage of stem cells |
| JP5676253B2 (ja) | 2008-04-30 | 2015-02-25 | 株式会社ジェノミックス | 生体内機能的細胞の高効率採取法 |
| JP5814549B2 (ja) | 2008-04-30 | 2015-11-17 | 株式会社ジェノミックス | 損傷組織の機能的再生促進医薬 |
| US8673580B2 (en) | 2008-04-30 | 2014-03-18 | Genomix Co., Ltd. | Agent for recruitment of bone-marrow-derived pluripotent stem cell into peripheral circulation |
| ES2609006T3 (es) | 2009-10-16 | 2017-04-18 | Rutgers, The State University Of New Jersey | Procedimeinto de tratamiento de lesión crónica de tejido nervioso usando una estrategia de terapia celular |
| JP5865703B2 (ja) | 2009-10-28 | 2016-02-17 | 株式会社ジェノミックス | 骨髄間葉系および／または多能性幹細胞の血中動員による組織再生促進剤 |
| CN102443064A (zh) | 2011-11-03 | 2012-05-09 | 刘誉 | 一种基于凝血酶活性的双靶向作用的嵌合多肽及其应用 |
| ES2660420T3 (es) | 2012-10-25 | 2018-03-22 | Genomix Co., Ltd. | Método novedoso para tratar infarto cardiaco utilizando fragmento de HMGB1 |
| US9688733B2 (en) | 2012-10-25 | 2017-06-27 | Genomix Co., Ltd. | Method for treating spinal cord injury using HMGB1 fragment |
-
2012
- 2012-04-03 PT PT181601121T patent/PT3358011T/pt unknown
- 2012-04-03 CN CN201710265231.9A patent/CN107188948B/zh active Active
- 2012-04-03 DK DK12777041.0T patent/DK2703487T3/en active
- 2012-04-03 CN CN201280031164.XA patent/CN103687946B/zh active Active
- 2012-04-03 CN CN202111352869.9A patent/CN114106139B/zh active Active
- 2012-04-03 US US14/114,395 patent/US10364276B2/en active Active
- 2012-04-03 PL PL18160112T patent/PL3358011T3/pl unknown
- 2012-04-03 ES ES12777041.0T patent/ES2684718T3/es active Active
- 2012-04-03 AU AU2012248676A patent/AU2012248676B2/en active Active
- 2012-04-03 ES ES18160112T patent/ES2788394T3/es active Active
- 2012-04-03 JP JP2013511983A patent/JP6069191B2/ja active Active
- 2012-04-03 WO PCT/JP2012/059113 patent/WO2012147470A1/ja not_active Ceased
- 2012-04-03 PT PT12777041T patent/PT2703487T/pt unknown
- 2012-04-03 EP EP12777041.0A patent/EP2703487B1/en active Active
- 2012-04-03 EP EP18160112.1A patent/EP3358011B1/en active Active
- 2012-04-03 DK DK18160112.1T patent/DK3358011T3/da active
- 2012-04-03 CA CA2834255A patent/CA2834255C/en active Active
- 2012-04-03 KR KR1020197017639A patent/KR102113809B1/ko active Active
- 2012-04-03 KR KR1020137031356A patent/KR101992807B1/ko active Active
- 2012-04-03 PL PL12777041T patent/PL2703487T3/pl unknown
-
2016
- 2016-11-02 JP JP2016214996A patent/JP6336549B2/ja active Active
-
2017
- 2017-05-31 AU AU2017203644A patent/AU2017203644B9/en active Active
- 2017-08-30 US US15/691,017 patent/US10550165B2/en active Active
-
2018
- 2018-05-02 JP JP2018088729A patent/JP6603964B2/ja active Active
-
2019
- 2019-08-02 AU AU2019210647A patent/AU2019210647B2/en active Active
- 2019-09-26 JP JP2019175276A patent/JP2020058344A/ja active Pending
- 2019-12-13 US US16/713,202 patent/US20200369736A1/en not_active Abandoned
-
2021
- 2021-08-06 JP JP2021129955A patent/JP2021191271A/ja active Pending
-
2022
- 2022-03-18 AU AU2022201894A patent/AU2022201894B2/en active Active
- 2022-12-21 US US18/069,421 patent/US20230212241A1/en not_active Abandoned
-
2023
- 2023-05-23 JP JP2023084251A patent/JP2023106525A/ja active Pending